20231205_INAF_Penyampaian Bukti Iklan_31545425_lamp1.pdf

(/
indofarma

Member of Biofarma Group

PENGUMUMAN
RAPAT UMUM PEMEGANG SAHAM LUAR BIASA
PT INDOFARMA Tbk

Bersama ini Direksi PT Indofarma Tbk (“Perseroan”) mengumumkan bahwa Rapat Umum
Pemegang Saham Luar Biasa Perseroan (“RUPSLB”) akan dilaksanakan pada hari Kamis,
tanggal 11 Januari 2024.

Sesuai dengan Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana
dan Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka juncto Peraturan
Otoritas Jasa Keuangan Nomor 16/POJK.04/2020 tentang Pelaksanaan Rapat Umum
Pemegang Saham Perusahaan Terbuka secara Elektronik (“Peraturan OJK”), maka
pemanggilan RUPSLB akan dilakukan melalui plafform eASY.KSEI yang dapat diakses melalui
htpps://akses.ksei.co.id, situs web penyedia e-RUPS, situs web Bursa Efek Indonesia, dan
situs web Perseroan (www.indofarma.id) pada tanggal 20 Desember 2023.

Para Pemegang Saham yang berhak menghadiri atau diwakili dalam RUPSLB adalah Para
Pemegang Saham yang namanya tercatat dalam Daftar Pemegang Saham Perseroan
dan/atau pemilik saldo saham Perseroan pada sub rekening efek di Penitipan Kolektif
PT Kustodian Sentral Efek Indonesia (“KSEI”) pada penutupan perdagangan saham di
Bursa Efek Indonesia pada tanggal 19 Desember 2023.

Sesuai dengan Peraturan OJK dan Pasal 23 Anggaran Dasar Perseroan, 1 (satu) Pemegang
Saham atau lebih yang mewakili 1/20 (satu per dua puluh) atau lebih dari jumlah seluruh
saham yang telah dikeluarkan Perseroan dengan hak suara yang sah dan Pemegang Saham
Seri A Dwi Warna berhak untuk mengusulkan mata acara RUPSLB yang wajib disampaikan
secara tertulis kepada Direksi Perseroan paling lambat 7 (tujuh) hari sebelum tanggal
Pemanggilan RUPSLB, yaitu tanggal 13 Desember 2023, dengan disertai alasan dan bahan
usulan mata acara RUPSLB, serta tidak bertentangan dengan peraturan perundang-
undangan.

Jakarta, 05 Desember 2023
PT Indofarma Tbk
Direksi

(/
indofarma

Member af Biofarma Group

ANNOUNCEMENT
EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
PT INDOFARMA Tbk

Hereby the Board of Directors of PT Indofarma Tbk (“Company”) announce that the
Extraordinary General Meeting of Shareholders of Company ("“EGMS”) will be held on
Thursday, January 11, 2024.

In accordance with Financial Services Authority Regulation Number 15/POJK.04/2020
concerning Plans and Implementation of General Meeting of Shareholders of Public
Companies in  conjunction with Financial Services Authority — Regulation
Number 16/POJK.04/2020 concerning the Implementation of Electronic General Meeting
of Shareholders of Public Companies ("OJK Regulation”), the summons for the EGMS will be
made through the eASY.KSEI platform which can be accessed through
htpps://akses.ksei.co.id, the website of the e-GMS provider, the website
of the Indonesia Stock Exchange, and the website of the Company (www.indofarma.id) on
December 20, 2023.

Shareholders who are entitled to attend or be represented in the EGMS are Shareholders
whose names are registered in the Shareholders Register of the Company and/or owners
of the Company's share balances in the securities sub-account in the Collective Custody
of PT Kustodian Sentral Efek Indonesia (“KSEI”) at the close of stock trading on the Indonesia
Stock Exchange on December 19, 2023.

In accordance with OJK Regulation and Article 23 of the Company's Articles of Association,
1 (one) Shareholder or more representing 1/20 (one twentieth) or more of the total shares
issued by the Company with valid voting rights and Series A Shareholders Dwi Warna has
the right to propose the agenda of the EGMS which must be submitted in writing to the
Board of Directors of the Company no later than 7 (seven) days before the date of the
summons for the EGMS, December 13, 2023, accompanied by the reasons and materials for
the proposed EGMS agenda, and does not conflict with the statutory regulations.

Jakarta, December 05, 2023
PT Indofarma Tbk
Board of Directors